vs

Side-by-side financial comparison of RxSight, Inc. (RXST) and WEST BANCORPORATION INC (WTBA). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $26.9M, roughly 1.2× WEST BANCORPORATION INC). WEST BANCORPORATION INC runs the higher net margin — 39.2% vs -28.1%, a 67.3% gap on every dollar of revenue. On growth, WEST BANCORPORATION INC posted the faster year-over-year revenue change (16.6% vs -18.9%). WEST BANCORPORATION INC produced more free cash flow last quarter ($12.4M vs $-2.3M). Over the past eight quarters, WEST BANCORPORATION INC's revenue compounded faster (17.3% CAGR vs 5.1%).

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

West Bancorporation Inc. is a regional financial holding company headquartered in the U.S. Midwest, primarily serving markets across Iowa and Minnesota. It provides a full suite of personal and commercial banking services, including deposit accounts, mortgage loans, business lending, and wealth management solutions for individual consumers, small-to-medium enterprises, and local organizational clients.

RXST vs WTBA — Head-to-Head

Bigger by revenue
RXST
RXST
1.2× larger
RXST
$32.6M
$26.9M
WTBA
Growing faster (revenue YoY)
WTBA
WTBA
+35.5% gap
WTBA
16.6%
-18.9%
RXST
Higher net margin
WTBA
WTBA
67.3% more per $
WTBA
39.2%
-28.1%
RXST
More free cash flow
WTBA
WTBA
$14.6M more FCF
WTBA
$12.4M
$-2.3M
RXST
Faster 2-yr revenue CAGR
WTBA
WTBA
Annualised
WTBA
17.3%
5.1%
RXST

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
RXST
RXST
WTBA
WTBA
Revenue
$32.6M
$26.9M
Net Profit
$-9.2M
$10.6M
Gross Margin
77.5%
Operating Margin
-34.8%
50.0%
Net Margin
-28.1%
39.2%
Revenue YoY
-18.9%
16.6%
Net Profit YoY
-54.1%
34.8%
EPS (diluted)
$-0.22
$0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RXST
RXST
WTBA
WTBA
Q1 26
$26.9M
Q4 25
$32.6M
$24.2M
Q3 25
$30.3M
$25.0M
Q2 25
$33.6M
$23.8M
Q1 25
$37.9M
$23.1M
Q4 24
$40.2M
$20.9M
Q3 24
$35.3M
$20.3M
Q2 24
$34.9M
$19.6M
Net Profit
RXST
RXST
WTBA
WTBA
Q1 26
$10.6M
Q4 25
$-9.2M
$7.4M
Q3 25
$-9.8M
$9.3M
Q2 25
$-11.8M
$8.0M
Q1 25
$-8.2M
$7.8M
Q4 24
$-5.9M
$7.1M
Q3 24
$-6.3M
$6.0M
Q2 24
$-6.1M
$5.2M
Gross Margin
RXST
RXST
WTBA
WTBA
Q1 26
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Operating Margin
RXST
RXST
WTBA
WTBA
Q1 26
50.0%
Q4 25
-34.8%
39.6%
Q3 25
-40.1%
45.8%
Q2 25
-41.6%
43.4%
Q1 25
-28.2%
43.4%
Q4 24
-21.5%
30.9%
Q3 24
-26.1%
36.6%
Q2 24
-23.9%
32.6%
Net Margin
RXST
RXST
WTBA
WTBA
Q1 26
39.2%
Q4 25
-28.1%
30.7%
Q3 25
-32.4%
37.3%
Q2 25
-35.0%
33.5%
Q1 25
-21.6%
34.0%
Q4 24
-14.8%
34.0%
Q3 24
-17.9%
29.3%
Q2 24
-17.4%
26.5%
EPS (diluted)
RXST
RXST
WTBA
WTBA
Q1 26
$0.61
Q4 25
$-0.22
$0.44
Q3 25
$-0.24
$0.55
Q2 25
$-0.29
$0.47
Q1 25
$-0.20
$0.46
Q4 24
$-0.14
$0.41
Q3 24
$-0.16
$0.35
Q2 24
$-0.16
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RXST
RXST
WTBA
WTBA
Cash + ST InvestmentsLiquidity on hand
$228.1M
$362.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.7M
$270.7M
Total Assets
$311.8M
$4.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RXST
RXST
WTBA
WTBA
Q1 26
$362.0M
Q4 25
$228.1M
$471.1M
Q3 25
$227.5M
$232.9M
Q2 25
$227.5M
$345.2M
Q1 25
$229.3M
Q4 24
$237.2M
$243.5M
Q3 24
$237.1M
Q2 24
$233.3M
Stockholders' Equity
RXST
RXST
WTBA
WTBA
Q1 26
$270.7M
Q4 25
$275.7M
$266.0M
Q3 25
$276.0M
$255.1M
Q2 25
$278.0M
$240.9M
Q1 25
$279.3M
$237.9M
Q4 24
$281.2M
$227.9M
Q3 24
$277.3M
$235.4M
Q2 24
$275.2M
$223.9M
Total Assets
RXST
RXST
WTBA
WTBA
Q1 26
$4.0B
Q4 25
$311.8M
$4.1B
Q3 25
$308.5M
$4.0B
Q2 25
$309.0M
$4.1B
Q1 25
$313.0M
$4.0B
Q4 24
$318.6M
$4.0B
Q3 24
$310.5M
$4.0B
Q2 24
$305.5M
$4.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RXST
RXST
WTBA
WTBA
Operating Cash FlowLast quarter
$-1.1M
$12.9M
Free Cash FlowOCF − Capex
$-2.3M
$12.4M
FCF MarginFCF / Revenue
-6.9%
46.0%
Capex IntensityCapex / Revenue
3.5%
1.8%
Cash ConversionOCF / Net Profit
1.22×
TTM Free Cash FlowTrailing 4 quarters
$-19.3M
$79.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RXST
RXST
WTBA
WTBA
Q1 26
$12.9M
Q4 25
$-1.1M
$46.5M
Q3 25
$-1.2M
$11.4M
Q2 25
$-4.4M
$13.5M
Q1 25
$-8.8M
$9.7M
Q4 24
$-4.3M
$39.8M
Q3 24
$650.0K
$12.9M
Q2 24
$-4.0M
$10.0M
Free Cash Flow
RXST
RXST
WTBA
WTBA
Q1 26
$12.4M
Q4 25
$-2.3M
$43.2M
Q3 25
$-1.8M
$10.8M
Q2 25
$-5.9M
$12.8M
Q1 25
$-9.4M
$8.3M
Q4 24
$-5.1M
$13.7M
Q3 24
$-453.0K
$7.0M
Q2 24
$-5.5M
$2.7M
FCF Margin
RXST
RXST
WTBA
WTBA
Q1 26
46.0%
Q4 25
-6.9%
178.3%
Q3 25
-5.8%
43.0%
Q2 25
-17.6%
53.6%
Q1 25
-24.8%
35.7%
Q4 24
-12.7%
65.6%
Q3 24
-1.3%
34.2%
Q2 24
-15.9%
14.0%
Capex Intensity
RXST
RXST
WTBA
WTBA
Q1 26
1.8%
Q4 25
3.5%
13.7%
Q3 25
1.9%
2.6%
Q2 25
4.6%
3.2%
Q1 25
1.5%
6.5%
Q4 24
2.1%
125.3%
Q3 24
3.1%
29.4%
Q2 24
4.4%
37.1%
Cash Conversion
RXST
RXST
WTBA
WTBA
Q1 26
1.22×
Q4 25
6.26×
Q3 25
1.23×
Q2 25
1.70×
Q1 25
1.24×
Q4 24
5.61×
Q3 24
2.17×
Q2 24
1.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

WTBA
WTBA

Segment breakdown not available.

Related Comparisons